Osteosarcoma (OS) is a rare primary malignant bone cancer affecting
mainly young individuals. Treatment typically consists of chemotherapy
and surgical tumor resection, which has undergone few improvements since
the 1970s. This therapeutic approach encounters several limitations
attributed to the tumor’s inherent chemoresistance, marked heterogeneity
and metastatic potential. Therefore, the development of in
vitroplatforms that closely mimic the OS pathophysiology is crucial to
understand tumor progression and discover effective anticancer
therapeutics. Contrary to 2D monolayer cultures and animal models,
3Din vitro platforms show promise in replicating the 3D tumor
macrostructure, cell-cell and cell-extracellular matrix interactions.
This review provides an overview of the biomanufacturing strategies
employed in developing 3D in vitro OS models, highlighting their
role in replicating different aspects of OS and improving OS anticancer
research and drug screening. A variety of 3D in vitro models are
explored, including both scaffold-free and scaffold-based models,
encompassing cell spheroids, hydrogels, and innovative approaches like
electrospun nanofibers, microfluidic devices and bioprinted constructs.
By examining the distinctive features of each model type, this review
offers insights into their potential transformative impact on the
landscape of OS research and therapeutic innovation, addressing the
challenges and future directions of 3D in vitro OS modeling.